We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIMI
4851
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$12K ﹤0.01%
357
AIHS icon
4852
Senmiao Technology Ltd
AIHS
$26.8M
$9K ﹤0.01%
167
BYU
4853
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$9K ﹤0.01%
53
-101
-66% -$20.3K
MKD
4854
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$9K ﹤0.01%
1,801
BHAT
4855
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
0
CYRN
4856
DELISTED
CYREN Ltd.
CYRN
$8K ﹤0.01%
657
ALZN icon
4857
Alzamend Neuro
ALZN
$7.04M
-33
Closed -$389K
BAOS icon
4858
Baosheng Media Group
BAOS
$1.12M
-681
Closed -$44K
BDL icon
4859
Flanigan's Enterprises
BDL
$77.3M
-5,340
Closed -$215K
BTCT icon
4860
BTC Digital
BTCT
$8.48M
-78
Closed -$45K
CNTA
4861
DELISTED
Centessa Pharmaceuticals
CNTA
-9,513
Closed -$211K
CWCO icon
4862
Consolidated Water Co
CWCO
$517M
-15,568
Closed -$182K
DSS icon
4863
DSS Inc
DSS
$5.15M
-11,318
Closed -$376K
EJH icon
4864
E-Home Household Service Holdings
EJH
$4.67M
0
-$287K
FRSX
4865
Foresight Autonomous Holdings
FRSX
$4.2M
-195
Closed -$104K
HUIZ
4866
Huize Holding Ltd
HUIZ
$13.5M
-3,384
Closed -$101K
JZXN icon
4867
Jiuzi Holdings
JZXN
$754K
-1
Closed -$91K
NCNA
4868
NuCana
NCNA
$5.99M
-3
Closed -$40K
NVNO
4869
enVVeno Medical
NVNO
$7.6M
-1,822
Closed -$437K
SMRT icon
4870
SmartRent
SMRT
$270M
-26,288
Closed -$323K
SY
4871
So-Young International
SY
$222M
-33,998
Closed -$326K
TRIB
4872
Trinity Biotech
TRIB
$9.03M
-93
Closed -$40K
VSTA
4873
DELISTED
Vasta Platform
VSTA
-15,730
Closed -$127K
WNW icon
4874
Meiwu Technology Co
WNW
$76.6M
0
-$91K
XPRO icon
4875
Expro Ltd
XPRO
$2.05B
-404,074
Closed -$7.35M

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.